APA (7th ed.) Citation

LR, M., H, L., HY, Y., J, C., MY, Y., YL, Z., . . . LF, T. (2026). Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer. The Kaohsiung journal of medical sciences, e70228. https://doi.org/10.1002/kjm2.70228

Chicago Style (17th ed.) Citation

LR, Miao, Liu H, Yu HY, Chen J, Yang MY, Zhang YL, Tu G, and Tang LF. "Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer." The Kaohsiung Journal of Medical Sciences 2026: e70228. https://doi.org/10.1002/kjm2.70228.

MLA (9th ed.) Citation

LR, Miao, et al. "Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer." The Kaohsiung Journal of Medical Sciences, 2026, p. e70228, https://doi.org/10.1002/kjm2.70228.